category,datetime,headline,id,image,related,source,summary,url
company,1768826280,Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan,138177946,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABT,Yahoo,Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.,https://finnhub.io/api/news?id=503f4b6fbb9bb2db559370a3732a67ffc25763a4cff27963a2a84b662fa84d15
company,1768826220,Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?,138177993,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABT,Yahoo,"ABT heads into Q4 earnings with adult nutrition in focus, as Ensure and Glucerna launches are expected to support modest segment growth.",https://finnhub.io/api/news?id=5726d83a89e11a2239f4363b3292e078d30064fe3db96baf1e87ec28b0df089d
company,1768813800,"""Microfluidics Market to Hit USD 105.13 Billion by 2033 with a CAGR of 12.22%""",138175748,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABT,Yahoo,"The microfluidics market offers opportunities in diagnostic healthcare, driven by the demand for precise, rapid PoCT solutions and reduced hospital visits. Adoption by key players like Abbott and Roche in IVD platforms for non-invasive testing enhances disease detection, supported by a diversified product and technology landscape. Microfluidics Market Microfluidics Market Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The ""Microfluidics Market Size, Share & Trends Analysis Report by Product (Microflu",https://finnhub.io/api/news?id=1000e79d56339b925655e81fbd5bc5f5c9730d3f77ae14cf6dc52473a883caa8
company,1768813500,Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever,138175734,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABT,Yahoo,Income investors can rely on these stocks.,https://finnhub.io/api/news?id=42b150a77563a93212d7323e14357a49e4822afb1632e7a79f3a44ef7ca19228
company,1768807800,Abbott Laboratories: Q4 Earnings On The Horizon,138176647,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2191006413/image_2191006413.jpg?io=getty-c-w1536,ABT,SeekingAlpha,"Abbott's revenue has been flat over 15 months with steady Q3 EPS of $1.30, 7% growth, and upcoming Q4 international segment updates. See why ABT stock is a hold.",https://finnhub.io/api/news?id=ffbb8e7adc65fca3a7f08a2238a6645cb06dcecf6ecd83661b988f7167beedc4
